Treatment of severe heart failure (HF) across the spectrum of LVEF with the SGLT2 inihbitor dapagliflozin appeared to be safe and effective in reducing the risk of cardiovascular death or worsening HF ...

The U.S. Food and Drug Administration (FDA) announced on March 3 that Philips is removing and discontinuing distribution of the Tack Endovascular System due to challenges necessitating additional ...

A recent State-of-the-Art Review published in JACC: Heart Failure provides evidence-based recommendations on how to best optimize the care of patients with heart failure (HF) through ...

American Board of Cardiovascular Medicine Chair Jeffrey Kuvin, MD, issued the following statement in response to the American Board of Medical Specialties denial of an independent board for cardiology ...

Notifying patients and their clinicians about incidental coronary calcium findings can encourage shared decision-making on preventive therapies and significantly boost statin use among high-risk ...

In patients undergoing PCI for de novo small-vessel coronary artery disease (SV-CAD), paclitaxel-coated balloon (PCB) angioplasty was associated with a reduction in the primary endpoint of major ...

Patients with heart failure (HF) who have worsening HF symptoms that require intensification of oral diuretics in the outpatient setting are common and associated with a poor prognosis, and finerenone ...

Tafamidis treatment in octogenarians diagnosed with wild-type transthyretin cardiomyopathy (ATTRwt-CM) improves survival without age affecting treatment efficacy, although mortality remains ...

JACC: Case Reports is seeking your patient success stories! Share your cases, vignettes and team discussions on patients with failing heart conditions who were ultimately treated successfully. Whether ...

Cardiopulmonary fitness and physical activity levels were significantly lower in children with inherited cardiac disease than in healthy controls, according to a study published Feb. 25 in JAMA ...